跳至主要内容
临床试验/NCT02770963
NCT02770963Unknown不适用

Efficacy of Acupuncture for Discogenic Sciatica: a Randomized Controlled Trial

Guang'anmen Hospital of China Academy of Chinese Medical Sciences1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
change from baseline in mean weekly VAS of leg pain

研究概览

简要总结

This trial is designed to evaluate the efficacy of acupuncture on pain relief for patients with discogenic sciatica compared with sham acupuncture.

详细描述

Background: Sciatica is primarily caused by herniated discs with nerve-root compression. Acupuncture may effectively relieve the pain of discogenic sciatica, but the evidence is limited.

Methods/Design: Sixty patients with discogenic sciatica will be recruited and randomized to receive acupuncture or sham-acupuncture at a 1:1 ratio. Patients in both groups will receive treatment 3 times per week for 4 weeks. The following acupoints will be used: Dachang shu (BL 25), Shenshu (BL 23), Weizhong (BL 40), and Chengshan (BL 57).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Unilateral leg pain diagnosed as discogenic sciatica;
  • •Sciatica patients with an average leg pain VAS of 40 mm or higher in the last 24 hours;
  • •Aged 18 to 75 years;
  • •Leg pains that correlate with CT or MRI findings of lumbar disc herniation;
  • •Patients who agree to follow the trial protocol.

排除标准

  • •Severe cases with central or giant or ruptured lumbar disc herniation, cauda equina syndrome, foot drop, or surgery requirements;
  • •Progressive neurological symptoms after 3 months of strict conservative treatment (e.g., nerve root adhesion, crossed straight-leg testing, or obvious muscle atrophy);
  • •Severe cardiovascular, liver, kidney, hematopoietic system diseases, autoimmune diseases, or poor nutritional status;
  • •Subjects with cognitive impairment;
  • •Subjects who received acupuncture for sciatica within the past month.

研究组 & 干预措施

Acupuncture

Experimental

Shenshu (BL23) on bilateral sides and Dachangshu (BL25), Weizhong (BL40), and Chengshan (BL57) on the affected side will be applied.

Huatuo Brand needle (0.3*75 mm) will be used for BL25 and Huatuo Brand needle (0.3*40mm) will be used for BL23, BL40 and BL57.

干预措施: Acupuncture (Procedure)

Sham acupuncture

Sham Comparator

The acupoints will be the same as the acupuncture group. Specially designed sham needles (0.3*25 mm) will be used . The sham needle consists of a needle handle, needle body, blunt tip and a sterile polyethylene cylindrical foam pad (identical to the pads in the acupuncture group).

干预措施: Sham acupuncture (Procedure)

结局指标

主要结局

change from baseline in mean weekly VAS of leg pain

时间窗: Baseline, weeks 1-4, week 16 and week 28

VAS uses a 100-mm line that is labeled at each end, and 0 mm represents no pain, and 100 mm represents unbearable pain. Patients will rate the VAS (average VAS of leg pain in the past 24 hours), and a researcher will record the VAS once weekly, generally at the third weekly treatment. The mean weekly VAS of leg pain over weeks 1-4 will be calculated as the sum VAS of each week divided by the number of weeks assessed.

次要结局

  • Change in mean weekly VAS of low back pain(Baseline, weeks 1-4, week 16 and week 28)
  • Oswestry disability index(Baseline, week 4, week 16 and week 28)
  • Patients' global impressions of improvement(week 4)
  • Patients' expectations for acupuncture(baseline)
  • Blinded evaluation(week 4)
  • Incidence of serious adverse events(up to 28 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Qin Yao

Postgraduate

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

研究点 (1)

Loading locations...

相似试验